EHMT2 and neoplasm: To study whether G9A knockdown affects tumor cell growth in vivo, we carried out xenograft assays in nude mice, and found that tumors derived from cells stably expressing G9A shRNA showed significantly slower growth rates and smaller tumor sizes, compared with those derived from cells expressing the control shRNA (Figure 2l).